The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5554-5559

  Vissers, Joost L M ^a   De Vries, I Jolanda M ^a   Schreurs, Marco W J ^a   Engelen, Linda P H ^a   Oosterwijk, Egbert ^a   Figdor, Carl G ^a   Adema, Gosse J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOGENICITY; KIDNEY CARCINOMA; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TUMOR IMMUNOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; DENDRITIC CELLS; EPITOPES; HLA-A2 ANTIGEN; HUMANS; INHIBITORY CONCENTRATION 50; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033230634     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Boon, T., Coulie, P. G., and van den Eynde, B. Tumor antigens recognized by T cells. Immunol. Today, 18: 267-268, 1997.
2. Rosenberg, S. A. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today, 18: 175-182, 1997.
3. Yannelli, J. R., Hyatt, C., McConnell, S., Hines, K., Jacknin, L., Parker, L., Sanders, M., and Rosenberg, S. A. Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience. Int. J. Cancer, 65: 413-421, 1996.
4. van den Eynde, B. J., and van der Bruggen, P. T cell defined tumor antigens. Curr. Opin. Immunol., 9: 684-693, 1997.
5. Jaeger, E., Bernhard, H., Romero, P., Ringhoffer, M., Arand, M., Karbach, J., Ilsemann, C., Hagedorn, M., and Knuth, A. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int. J. Cancer, 66: 162-169, 1996.
6. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med., 4: 328-332, 1998.
7. Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., Wunderlich, J. R., Parkhurst, M. R., Kawakami, Y., Seipp, C. A., Einhorn, J. H., and White, D. E. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med., 4: 269 -270, 1998.
8. Freed, S. Z., Halperin, J. P., and Gordon, M. Idiopathic regression of metastases from renal cell carcinoma. J. Urol., 118: 538-542, 1977.
9. Marcus, S. G., Choyke, P. L., Reiter, R., Jaffe, G. S., Alexander, R. B., Lineham, W. M., Rosenberg, S. A., and Walther, M. M. Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy. J. Urol., 150: 463-466, 1993.
10. Gleave, M. E., Elhilali, M., Fradet, Y., Davis, I., Venner, P., Saad, F., Klotz, L. H., Moore, M. J., Paton, V., and Bajamonde, A. Interferon γ-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologie Oncology Group. N. Engl. J. Med., 338: 1265-1271, 1998.
11. Koo, A. S., Tso, C. L., Shimabukuro, T., Peyret, C., deKernion, J. B., and Belldegrun, A. Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma. J. Immunother., 10: 347-354, 1991.
12. Finke, J. H., Rayman, P., Edinger, M., Tubbs, R. R., Stanley, J., Klein, E., and Bukowski, R. Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T-cell line. J. Immunother., 11: 1-11, 1992.
13. Schendel, D. J., Gansbacher, B., Oberneder, R., Kriegmair, M., Hofstetter, A., Riethmuller, G., and Segurado, O. G. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J. Immunol., 151: 4209-4220, 1993.
14. Gaugler, B., Brouwenstijn, N., Vantomme, V., Szikora, J. P., van der Spek, C. W., Patard, J. J., Boon, T., Schrier, P., and van den Eynde, B. J. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics, 44: 323-330, 1996.
15. Brandle, D., Brasseur, F., Weynants, P., Boon, T., and van den Eynde, B. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J. Exp. Med., 183: 2501-2508, 1996.
16. Brossart, P., Stuhler, G., Flad, T., Stevanovic, S., Rammensee, H. G., Kanz, L., and Brugger, W. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res., 58: 732-736, 1998.
17. Oosterwijk, E., Ruiter, D. J., Hoedemaeker, P. J., Pauwels, E. K., Jonas, U., Zwartendijk, J., and Warnaar, S. O. Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney. Int. J. Cancer, 38: 489-494, 1986.
18. Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J. P., Zelnik, V., Opavsky, R., Zal'ovicova, M., Liao, S., Portetelle, D., Stanbridge, E. J., Závada, J., Burny, A., and Kettmann, R. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene, 9: 2877-2888, 1994.
19. Saarnio, J., Parkkila, S., Parkkila, A. K., Haukipuro, K., Pastorekova, S., Pastorek, J., Kairaluoma, M. I., and Karttunen, T. J. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am. J. Pathol., 153: 279-285, 1998.
20. Oosterwijk, E., Debruyne, F. M., and Schalken, J. A. The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma. Semin. Oncol., 22: 34-41, 1995.
21. Opavsky, R., Pastorekova, S., Zelnik, V., Gibadulinova, A., Stanbridge, E. J., Zavada, J., Kettmann, R., and Pastorek, J. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics, 33: 480-487, 1996.
22. Bakker, A. B. H., Schreurs, M. W. J., De Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med., 179: 1005-1009, 1994.
23. Vitiello, A., Marchesini, D., Furze, J., Sherman, L. A., and Chesnut, R. W. Analysis of the HLA-restricted influenza-specific cytotoxic T-lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med., 173: 1007-1015, 1991.
24. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.), 351: 290-296, 1991.
25. D'Amaro, J., Houbiers, J. G., Drijfhout, J. W., Brandt, R. M., Schipper, R., Bavinck, J. N., Melief, C. J., and Kast, W. M. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. Hum. Immunol., 43: 13-18, 1995.
26. Salter, R. D., Howell, D. N., and Cresswell, P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics, 21: 235-246, 1985.
27. Nijman, H. W., Houbiers, J. G., Vierboom, M. P., van der Burg, S. H., Drijfhout, J. W., D'Amaro, J., Kenemans, P., Melief, C. J., and Kast, W. M. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol., 23: 1215-1219, 1993.
28. Parham, P. and Brodsky, F. M. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol., 3: 277-299, 1981.
29. van der Burg, S. H., Ras, E., Drijfhout, J. W., Benckhuijsen, W. E., Bremers, A. J., Melief, C. J., and Kast, W. M. An HLA class I peplide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. Hum. Immunol., 44: 189-198, 1995.
30. Milich, D. R., Hughes, J. L., McLachlan, A., Thornton, G. B., and Moriarty, A. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc. Natl. Acad. Sci. USA, 85: 1610-1614, 1988.
31. Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D., and Schuler, G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods, 196: 137-151, 1996.
32. Tsai, V., Southwood, S., Sidney, J., Sakaguchi, K., Kawakami, Y., Appella, E., Sette, A., and Celis, E. Identification of subdominant CTL epitopes of the gp100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J. Immunol., 158: 1796-1802, 1997.
33. Bakker, A. B. H., Schreurs, M. W. J., Tafazzul, G., De Boer, A. J., Kawakami, Y., Adema, G. J., and Figdor, C. G. Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line. Int. J. Cancer, 62: 97-102, 1995.
34. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., Sidney, J., Delguercio, M. F., Southwood, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., and Chisari, F. V. The relationship between class I finding affinity and iminunogenicity of potential cytotoxic T cell epitopes. J. Immunol., 153: 5586-5592, 1994.
35. Ressing, M. E., Sette, A., Brandt, R. M., Ruppert, J., Wentworth, P. A., Hartman, M., Oseroff, C., Grey, H. M., Melief, C. J., and Kast, W. M. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J. Immunol., 154: 5934-5943, 1995.
36. Houbiers, J. G., Nijman, H. W., van der Burg, S. H., Drijfhout, J. W., Kenemans, P., van de Velde, C. J., Brand, A., Momburg, F., Kast, W. M., and Melief, C. J. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur. J. Immunol., 23: 2072-2077, 1993.
37. Wentworth, P. A., Celis, E., Crimi, C., Stitely, S., Hale, L., Tsai, V., Serra, H. M., Del Guercio, M. F., Livingston, B., Alazard, D., Fikes, J., Kubo, R. T., Grey, H. M., Chesnut, R. W., Chisari, F. V., and Seite, A. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol., 32: 603-612, 1995.
38. Matsui, M., Moots, R. J., Warburton, R. J., Peace-Brewer, A. L., Tussey, L. G., Quinn, D. G., McMichael, A. J., and Frelinger, J. A. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition. J. Immunol., 154: 1088-1096, 1995.
39. Sahin, U., Tureci, O., and Pfreundschuh, M. Serological identification of human tumor antigens. Curr. Opin. Immunol., 9: 709-716, 1997.